Skip to main navigation Skip to search Skip to main content

Definition of urinary tract infection and assessment of efficacy in drug trials - A laboratory perspective

  • R. C.B. Slack*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

1. There appears to be no difference between study groups of patients with symptomatic UTI with regard to bacteriuria and nitrite positivity. However, a full prospective study should confirm this. 2. Most methods currently used are not sufficiently sensitive to detect low numbers of bacteria and to distinguish between contamination and infecting organisms. 3. Screening methods are easy and cheap to perform and select a similar population to those included on the criteria of low counts. It would seem to be sensible to continue with present criteria and to perform studies to determine the practicalities of using low coliform counts. All treatment failures must be carefully evaluated.

Original languageEnglish
Pages (from-to)S155-S156
JournalInfection
Volume20
Issue number3 Supplement
DOIs
Publication statusPublished - May 1992
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Definition of urinary tract infection and assessment of efficacy in drug trials - A laboratory perspective'. Together they form a unique fingerprint.

Cite this